NLS Pharmaceutics Ltd. Warrant
NLSPW
NLSPW
5 hedge funds and large institutions have $45.4K invested in NLS Pharmaceutics Ltd. Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$55 |
Top Sellers
| 1 |
CS
Clear Street
New York
|
$477 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $28.1K | – | – | – |
|
|
ACM
2
Altium Capital Management
New York
| $11.2K | – | – | – |
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $5.61K | – | – | – |
|
|
CS
4
Clear Street
New York
| $477 | -$6 | -100 | -1% |
|
|
5
UBS Group
Zurich,
Switzerland
| $55 | +$55 | +1,000 | New |
|